About the journal
Molecular Cell is a journal published by Elsevier BV in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 9,080 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1097-4164 · 1097-2765
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 9,080 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/molecular-cell
Index listings
- MEDLINE · 1997-01-01
- PUBMED · 2004-01-16
- Indexing
- MEDLINE · PUBMED
- APC
- 9,080 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 259 days received→accepted — computed from PubMed (n=99)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
10604
Last recorded publication year
2026
h-index
531
i10-index
8689
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 62%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9802571
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- RNA Research and Splicing
- RNA Research and Splicing
- RNA modifications and cancer
- RNA modifications and cancer
- RNA and protein synthesis mechanisms
- Genomics and Chromatin Dynamics
- RNA and protein synthesis mechanisms
- Genomics and Chromatin Dynamics
Show all subjects (50)
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Bacterial Genetics and Biotechnology
- Bacterial Genetics and Biotechnology
- Microtubule and mitosis dynamics
- Microtubule and mitosis dynamics
- Mitochondrial Function and Pathology
- Mitochondrial Function and Pathology
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Cancer-related gene regulation
- Cancer-related gene regulation
- Endoplasmic Reticulum Stress and Disease
- Endoplasmic Reticulum Stress and Disease
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- interferon and immune responses
- interferon and immune responses
- RNA regulation and disease
- RNA regulation and disease
- Fungal and yeast genetics research
- Fungal and yeast genetics research
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- DNA and Nucleic Acid Chemistry
- DNA and Nucleic Acid Chemistry
- Chromosomal and Genetic Variations
- Chromosomal and Genetic Variations
- Cellular transport and secretion
- Cellular transport and secretion
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ